Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
暂无分享,去创建一个
R. Storb | B. Storer | F. Appelbaum | M. Flowers | S. Forman | W. Bensinger | P. Parker | K. Blume | L. Johnston | Alice V B Matos | P. Martin
[1] Á. Urbano-Ispizua. Chronic graft versus host disease after allogeneic peripheral blood transplantation. , 2003, Haematologica.
[2] S. Heimfeld,et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. , 2001, Blood.
[3] K. Cleary,et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. , 2001, Blood.
[4] D. Paniagua,et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Piantadosi,et al. Development of a prognostic model for grading chronic graft-versus-host disease. , 2001, Blood.
[6] R Storb,et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.
[7] N. Schmitz,et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). , 2000, Blood.
[8] S. Singhal,et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial , 2000, The Lancet.
[9] J. Bourhis,et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[11] J. Garcia-conde,et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study , 1998, Bone Marrow Transplantation.
[12] F. Aranha,et al. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies , 1998, Bone Marrow Transplantation.
[13] J Wagner,et al. The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation , 1998, Bone Marrow Transplantation.
[14] N. Schmitz,et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation , 1998, Bone Marrow Transplantation.
[15] J. Armitage,et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Y. Hyjazi,et al. Illegal or unsafe abortion in Guinea. , 1996, African journal of fertility, sexuality, and reproductive health.
[17] W. Krenger,et al. Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.
[18] J. Klein,et al. Statistical Models Based On Counting Process , 1994 .
[19] C. Perreault,et al. Minor histocompatibility antigens. , 1990, Blood.
[20] L. VázquezSell,et al. Graft-versus-host disease. , 1991, The New England journal of medicine.
[21] H. Deeg,et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.
[22] H. Deeg,et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. , 1983, Annals of internal medicine.
[23] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.